CN103690832A - Traditional Chinese medicinal composition for treating viral myocarditis - Google Patents

Traditional Chinese medicinal composition for treating viral myocarditis Download PDF

Info

Publication number
CN103690832A
CN103690832A CN201310741113.2A CN201310741113A CN103690832A CN 103690832 A CN103690832 A CN 103690832A CN 201310741113 A CN201310741113 A CN 201310741113A CN 103690832 A CN103690832 A CN 103690832A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
viral myocarditis
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310741113.2A
Other languages
Chinese (zh)
Other versions
CN103690832B (en
Inventor
梁慧慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qidong Jiulong Shunzhou Toy Factory
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310741113.2A priority Critical patent/CN103690832B/en
Publication of CN103690832A publication Critical patent/CN103690832A/en
Application granted granted Critical
Publication of CN103690832B publication Critical patent/CN103690832B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

本发明公开了一种治疗病毒性心肌炎的中药组合物,该药由如下重量份的中药材原料制备而成:黄连10-18份、千层塔20-30份、薤白20-30份、五味子10-18份、竹叶20-30份、苏叶10-18份、薏苡仁25-40份、蒺藜8-15份、炙甘草6-12份、葶苈子10-18份。本发明的中药组合物治疗原发性病毒性心肌炎的临床疗效显著,不仅能明显改善症状,而且能够降低AST、CK、CK-MB、LDH、a-HBDB水平,调节免疫,改善心功能。 The invention discloses a traditional Chinese medicine composition for treating viral myocarditis. The medicine is prepared from the following Chinese medicinal materials in parts by weight: 10-18 parts of Coptidis Rhizome, 20-30 parts of Melaleuca Pagoda, 20-30 parts of Scallops, and Schisandra 10-18 parts, 20-30 parts of bamboo leaves, 10-18 parts of perilla leaves, 25-40 parts of coix seed, 8-15 parts of Tribulus terrestris, 6-12 parts of roasted licorice, 10-18 parts of Tinglizi. The traditional Chinese medicine composition of the invention has remarkable clinical curative effect in treating primary viral myocarditis, not only can obviously improve symptoms, but also can reduce the levels of AST, CK, CK-MB, LDH and a-HBDB, regulate immunity and improve heart function.

Description

一种治疗病毒性心肌炎的中药组合物A kind of traditional Chinese medicine composition for treating viral myocarditis

技术领域 technical field

本发明属于中医药技术领域,具体而言,涉及一种治疗病毒性心肌炎的中药组合物。 The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to a traditional Chinese medicine composition for treating viral myocarditis.

背景技术 Background technique

病毒性心肌炎可发生于任何年龄,以青少年多见,该病疗程长、病情易反复,治疗不及时可迁延成慢性甚至发展成心肌病,严重影响儿童健康。病毒性心肌炎早期主要表现病毒直接损害心肌,后期主要以免疫损伤为主。病毒性心肌炎的发病机制尚不完全明了,但病毒对心肌细胞的直接溶解作用和病毒诱导产生对心肌组织的自身免疫损害是病毒性心肌炎的重要发病机制。近年来,其发病率呈上升趋势,且无特效治疗方法。西药治疗主要针对原发感染和心肌炎症两方面,但现有抗病毒药物对病毒性心肌炎的疗效不能肯定。祖国医学认为,病毒性心肌炎属“心悸”、“胸痹”等证范畴。而且,中医药在此方面显示出明显优势。 Viral myocarditis can occur at any age, and it is more common in adolescents. The course of treatment is long and the condition is prone to recurrence. If the treatment is not timely, it can be chronic and even develop into cardiomyopathy, which seriously affects the health of children. In the early stage of viral myocarditis, the main manifestation is that the virus directly damages the myocardium, and in the later stage, the main manifestation is immune injury. The pathogenesis of viral myocarditis is not yet fully understood, but the direct lytic effect of the virus on myocardial cells and the autoimmune damage induced by the virus to myocardial tissue are important pathogenesis of viral myocarditis. In recent years, its incidence is on the rise, and there is no specific treatment. Western medicine treatment is mainly aimed at two aspects of primary infection and myocardial inflammation, but the curative effect of existing antiviral drugs on viral myocarditis is uncertain. Traditional Chinese medicine believes that viral myocarditis belongs to the categories of "palpitations" and "chest pain". Moreover, traditional Chinese medicine has shown obvious advantages in this respect.

发明内容 Contents of the invention

本发明的目的在于通过对传统药物药理进行研究后重新组方,提供一种疗效好、见效快、副作用小的治疗病毒性心肌炎的中药组合物。 The purpose of the present invention is to provide a traditional Chinese medicine composition for treating viral myocarditis with good curative effect, quick effect and little side effect by recombining prescriptions after studying the pharmacology of traditional medicines.

本发明的目的是这样实现的: The purpose of the present invention is achieved like this:

一种治疗病毒性心肌炎的中药组合物,由如下重量份的中药材原料制备而成:黄连10-18份、千层塔20-30份、薤白20-30份、五味子10-18份、竹叶20-30份、苏叶10-18份、薏苡仁25-40份、蒺藜8-15份、炙甘草6-12份、葶苈子10-18份。 A traditional Chinese medicine composition for treating viral myocarditis, which is prepared from the following raw materials of Chinese medicinal materials in parts by weight: 10-18 parts of Coptidis Rhizoma, 20-30 parts of Melaleuca, 20-30 parts of Scallops, 10-18 parts of Schisandra, bamboo 20-30 parts of leaves, 10-18 parts of perilla leaves, 25-40 parts of Coix seed, 8-15 parts of Tribulus terrestris, 6-12 parts of roasted licorice, 10-18 parts of Tinglizi.

优选地,如上所述治疗病毒性心肌炎的中药组合物,它由如下重量份的中药材原料制备而成:黄连13-15份、千层塔23-27份、薤白23-27份、五味子13-15份、竹叶23-27份、苏叶13-15份、薏苡仁30-35份、蒺藜10-13份、炙甘草8-10份、葶苈子13-15份。 Preferably, the traditional Chinese medicine composition for treating viral myocarditis as described above is prepared from the following Chinese medicinal materials in parts by weight: Coptidis 13-15 parts, Melaleuca 23-27 parts, Scallops 23-27 parts, Schisandra 13 parts -15 parts, 23-27 parts of bamboo leaves, 13-15 parts of perilla leaves, 30-35 parts of coix seed, 10-13 parts of Tribulus terrestris, 8-10 parts of roasted licorice, 13-15 parts of Tinglizi.

在本发明的一个最优选的实施例中,如上所述的中药组合物由如下重量份的中药材原料制备而成:黄连14份、千层塔25份、薤白25份、五味子14份、竹叶25份、苏叶14份、薏苡仁32份、蒺藜12份、炙甘草8份、葶苈子14份。 In a most preferred embodiment of the present invention, the above-mentioned traditional Chinese medicine composition is prepared from the following raw materials of Chinese medicinal materials in parts by weight: 14 parts of Coptidis Rhizome, 25 parts of Melaleuca, 25 parts of Scallop, 14 parts of Schisandra, bamboo 25 parts of leaves, 14 parts of perilla leaves, 32 parts of coix seed, 12 parts of Tribulus terrestris, 8 parts of roasted licorice, and 14 parts of Tinglizi.

优选地,上述的治疗病毒性心肌炎的中药组合物是口服制剂。 Preferably, the above-mentioned traditional Chinese medicine composition for treating viral myocarditis is an oral preparation.

再进一步优选地,上述的治疗病毒性心肌炎的中药组合物是颗粒剂。 Still further preferably, the above-mentioned traditional Chinese medicine composition for treating viral myocarditis is a granule.

本发明涉及的中药材具有如下来源:黄连选用毛茛科植物黄连Coptis chinensis Franch.三角叶黄连Coptis deltoidea C.Y.Chenget Hsiao或云连Coptis teeta Wall.的干燥根茎。千层塔选用石杉科石杉属多年生草本植物蛇足石杉的全草。薤白选用百合科植物小根蒜 Allium macrostemon Bge.的干燥鳞茎,夏、秋二季采挖,洗净,除去须根,蒸透或置沸水中烫透,晒干。竹叶选用禾本科植物淡竹的干燥叶。苏叶选用唇形科植物皱紫苏、尖紫苏等的干燥叶。薏苡仁选用禾本科植物薏苡Coix lacryma-jobi L. var. meyuan (Romen.) Stapf的种仁。蒺藜选用蒺藜科植物蒺藜Tribulus terrestris L.的干燥成熟果实。炙甘草选用为双子叶植物豆科 Leguminosae甘草 Glycyrrhiza uralensis Fisch. ,胀果甘草 G. inflata Bat., 或光果甘草 G. glabra L. 的根及根茎用蜜烘制而得。葶苈子选用独行菜(Lepidium apetalum)的成熟种子。 The Chinese medicinal materials involved in the present invention have the following sources: the rhizomes of Coptis chinensis Franch, Coptis deltoidea C.Y. Chenget Hsiao or Coptis teeta Wall. The thousand-story pagoda is made of the whole herb of the perennial herb Huperus serrata of the Huperzaceae family. The dried bulbs of Allium macrostemon Bge. are selected from Liliaceae plant Allium macrostemon Bge. They are excavated in summer and autumn, washed, removed fibrous roots, steamed or scalded in boiling water, and dried in the sun. Bamboo leaves are selected from the dry leaves of Gramineae Pachyphyllum. Perilla leaves are selected from the dry leaves of Lamiaceae plants such as wrinkled perilla and pointed perilla. Coix lacryma-jobi L. var. meyuan (Romen.) Stapf seeds are selected from the gramineous plant Coix lacryma-jobi L. var. meyuan (Romen.) Stapf. Tribulus terrestris is selected from the dried ripe fruit of Tribulus terrestris L. of Tribulus terrestris plant. Roasted licorice is obtained by roasting the root and rhizome of Glycyrrhiza uralensis Fisch., G. inflata Bat., or G. glabra L. Tinglizi is selected from the mature seeds of Lepidium apetalum.

将上述各中药材制备成本发明的复方颗粒剂的制备方法,包括如下步骤:按处方量称取清洗干净的黄连10-18份、千层塔20-30份、薤白20-30份、五味子10-18份、竹叶20-30份、苏叶10-18份、薏苡仁25-40份、蒺藜8-15份、炙甘草6-12份和葶苈子10-18份,合并,加水煎煮两次,第一次加水为药材重量的10倍量,煎煮1.5h,第二次加水为药材重量的8倍量,煎煮1.5h,合并煎液,0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏,加95%(v/v)乙醇使含醇量达75%(v/v), 搅拌,静置24小时,过滤,滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25,并回收乙醇,得浓缩液,将浓缩液喷雾干燥(条件为进风温度为100℃,出风温度为80℃,物料温度为80℃, 雾化压力为0.2兆帕,喷雾速度为5ml/s。),粉碎过80目筛,得到清膏粉;按照清膏粉:糊精1:1~3的重量比称取清膏粉、糊精,将清膏粉与糊精投入槽型混合机中,搅拌20分钟,边搅拌边缓缓加入适量乙醇溶液,至制成软材,用12目不锈钢筛制粒,65~75℃干燥2小时,取出,放凉即得所述的颗粒剂。 The preparation method of the compound granules prepared from the above-mentioned Chinese medicinal materials comprises the following steps: weighing 10-18 parts of Coptis chinensis, 20-30 parts of Melaleuca pagoda, 20-30 parts of Scallops, and 10 parts of Schisandra chinensis according to the prescription amount -18 parts, 20-30 parts of bamboo leaves, 10-18 parts of sage leaves, 25-40 parts of coix seed, 8-15 parts of Tribulus terrestris, 6-12 parts of roasted licorice and 10-18 parts of Tinglizi, combine and decoct Boil twice, add water 10 times the weight of the medicinal material for the first time, decoct for 1.5h, add water for the second time 8 times the weight of the medicinal material, decoct for 1.5h, combine the decoction, 0.07MPa, 60-70℃ Concentrate under reduced pressure to extract with a relative density of 1.15 at 65°C, add 95% (v/v) ethanol to make the alcohol content reach 75% (v/v), stir, let stand for 24 hours, filter, and the filtrate is at 0.07MPa , Concentrate under reduced pressure at 65°C to a relative density of 1.25 at 65°C, and recover ethanol to obtain a concentrated solution, which is spray-dried (conditions are that the inlet air temperature is 100°C, the outlet air temperature is 80°C, and the material temperature 80°C, atomization pressure 0.2 MPa, spray speed 5ml/s), crushed through 80-mesh sieve to obtain clear paste powder; Paste powder and dextrin, put the clear paste powder and dextrin into the tank mixer, stir for 20 minutes, slowly add an appropriate amount of ethanol solution while stirring, until the soft material is made, granulate with a 12-mesh stainless steel sieve, 65~ Dry at 75°C for 2 hours, take it out, and let it cool to obtain the granules.

本发明的中药组合物治疗原发性病毒性心肌炎的临床疗效显著,不仅能明显改善症状,而且能够降低AST、CK、CK-MB、LDH、a-HBDB水平,调节免疫,改善心功能,提示其作用可能与增加心肌供血,改善心肌代谢,营养受损心肌,改善机体免疫状态等有关。另外,本发明的药物具有医疗费用低,患者容易接受,毒副反应小的特点。 The traditional Chinese medicine composition of the present invention has remarkable clinical curative effect in treating primary viral myocarditis, not only can obviously improve symptoms, but also can reduce AST, CK, CK-MB, LDH, a-HBDB levels, regulate immunity, improve heart function, prompting Its effect may be related to increasing myocardial blood supply, improving myocardial metabolism, nourishing damaged myocardium, and improving the immune status of the body. In addition, the medicine of the present invention has the characteristics of low medical expenses, easy acceptance by patients, and little toxic and side effects.

具体实施方式 Detailed ways

以下是本发明的具体实施例,对本发明的技术方案做进一步作描述,但是本发明的保护范围并不限于这些实施例。凡是不背离本发明构思的改变或等同替代均包括在本发明的保护范围之内。 The following are specific examples of the present invention, and further describe the technical solution of the present invention, but the protection scope of the present invention is not limited to these examples. All changes or equivalent substitutions that do not depart from the concept of the present invention are included in the protection scope of the present invention.

实施例1  Example 1

生药处方:黄连14份、千层塔25份、薤白25份、五味子14份、竹叶25份、苏叶14份、薏苡仁32份、蒺藜12份、炙甘草8份、葶苈子14份。 Herbal medicine prescription: Coptidis 14 parts, Melaleuca 25 parts, Scallop 25 parts, Schisandra chinensis 14 parts, bamboo leaves 25 parts, perilla leaves 14 parts, coix seed 32 parts, tribulus terrestris 12 parts, roasted licorice 8 parts, Tinglizi 14 parts .

制备工艺:按处方量称取清洗干净的上述中药材,合并,加水煎煮两次,第一次加水为药材重量的10倍量,煎煮1.5h,第二次加水为药材重量的8倍量,煎煮1.5h,合并煎液,0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏,加95%(v/v)乙醇使含醇量达75%(v/v), 搅拌,静置24小时,过滤,滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25,并回收乙醇,得浓缩液,将浓缩液喷雾干燥(条件为进风温度为100℃,出风温度为80℃,物料温度为80℃, 雾化压力为0.2兆帕,喷雾速度为5ml/s。),粉碎过80目筛,得到清膏粉;按照清膏粉:糊精1:2.5的重量比称取清膏粉、糊精,将清膏粉与糊精投入槽型混合机中,搅拌20分钟,边搅拌边缓缓加入55%乙醇,至制成软材,用12目不锈钢筛制粒,65~75℃干燥2小时,取出,放凉即得所述的颗粒剂,按每袋15g包装。 Preparation process: Weigh the above-mentioned Chinese medicinal materials cleaned according to the prescription amount, combine them, add water to decoct twice, add water for the first time to 10 times the weight of the medicinal materials, decoct for 1.5 hours, and add water for the second time to 8 times the weight of the medicinal materials amount, decoct for 1.5h, combine the decoction, concentrate under reduced pressure at 0.07MPa, 60-70°C to an extract with a relative density of 1.15 at 65°C, add 95% (v/v) ethanol to make the alcohol content reach 75% (v/v), stir, stand still for 24 hours, filter, the filtrate is concentrated under reduced pressure at 0.07MPa and 65°C to a relative density of 1.25 at 65°C, and ethanol is recovered to obtain a concentrated solution, which is spray-dried (Conditions are that the inlet air temperature is 100°C, the outlet air temperature is 80°C, the material temperature is 80°C, the atomization pressure is 0.2 MPa, and the spray speed is 5ml/s.), crushed through a 80-mesh sieve to obtain clear cream powder ;Weigh the cream powder and dextrin according to the weight ratio of cream powder: dextrin 1:2.5, put the cream powder and dextrin into the tank mixer, stir for 20 minutes, and slowly add 55% ethanol while stirring , until soft material is made, granulate with 12 mesh stainless steel sieves, dry at 65~75°C for 2 hours, take out, let cool to get the described granules, pack in 15g per bag.

实施例2  Example 2

生药处方:黄连16份、千层塔22份、薤白26份、五味子10份、竹叶28份、苏叶15份、薏苡仁35份、蒺藜8份、炙甘草8份、葶苈子18份。 Herbal medicine prescription: Coptidis 16 parts, Melaleuca 22 parts, Allium 26 parts, Schisandra 10 parts, Bamboo leaves 28 parts, Perilla leaves 15 parts, Coix seed 35 parts, Tribulus terrestris 8 parts, Roasted licorice 8 parts, Tinglizi 18 parts .

制备工艺:按处方量称取清洗干净的上述中药材,合并,加水煎煮两次,第一次加水为药材重量的10倍量,煎煮1.5h,第二次加水为药材重量的8倍量,煎煮1.5h,合并煎液,0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏,加95%(v/v)乙醇使含醇量达75%(v/v), 搅拌,静置24小时,过滤,滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25,并回收乙醇,得浓缩液,将浓缩液喷雾干燥(条件为进风温度为100℃,出风温度为80℃,物料温度为80℃, 雾化压力为0.2兆帕,喷雾速度为5ml/s。),粉碎过80目筛,得到清膏粉;按照清膏粉:糊精1:3的重量比称取清膏粉、糊精,将清膏粉与糊精投入槽型混合机中,搅拌20分钟,边搅拌边缓缓加入55%乙醇,至制成软材,用12目不锈钢筛制粒,65~75℃干燥2小时,取出,放凉即得所述的颗粒剂,按每袋15g包装。 Preparation process: Weigh the above-mentioned Chinese medicinal materials cleaned according to the prescription amount, combine them, add water to decoct twice, add water for the first time to 10 times the weight of the medicinal materials, decoct for 1.5 hours, and add water for the second time to 8 times the weight of the medicinal materials amount, decoct for 1.5h, combine the decoction, concentrate under reduced pressure at 0.07MPa, 60-70°C to an extract with a relative density of 1.15 at 65°C, add 95% (v/v) ethanol to make the alcohol content reach 75% (v/v), stir, stand still for 24 hours, filter, the filtrate is concentrated under reduced pressure at 0.07MPa and 65°C to a relative density of 1.25 at 65°C, and ethanol is recovered to obtain a concentrated solution, which is spray-dried (Conditions are that the inlet air temperature is 100°C, the outlet air temperature is 80°C, the material temperature is 80°C, the atomization pressure is 0.2 MPa, and the spray speed is 5ml/s.), crushed through a 80-mesh sieve to obtain clear cream powder ;Weigh the clear cream powder and dextrin according to the weight ratio of clear cream powder: dextrin 1:3, put the clear cream powder and dextrin into the tank mixer, stir for 20 minutes, and slowly add 55% ethanol while stirring , until soft material is made, granulate with 12 mesh stainless steel sieves, dry at 65~75°C for 2 hours, take out, let cool to get the described granules, pack in 15g per bag.

实施例3  Example 3

生药处方:黄连10份、千层塔25份、薤白28份、五味子15份、竹叶25份、苏叶12份、薏苡仁40份、蒺藜12份、炙甘草12份、葶苈子10份。 Herbal medicine prescription: Coptis 10 parts, Melaleuca 25 parts, Allium 28 parts, Schisandra chinensis 15 parts, Bamboo leaves 25 parts, Perilla leaves 12 parts, Coix seed 40 parts, Tribulus terrestris 12 parts, Roasted licorice 12 parts, Tinglizi 10 parts .

制备工艺:按处方量称取清洗干净的上述中药材,合并,加水煎煮两次,第一次加水为药材重量的10倍量,煎煮1.5h,第二次加水为药材重量的8倍量,煎煮1.5h,合并煎液,0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏,加95%(v/v)乙醇使含醇量达75%(v/v), 搅拌,静置24小时,过滤,滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25,并回收乙醇,得浓缩液,将浓缩液喷雾干燥(条件为进风温度为100℃,出风温度为80℃,物料温度为80℃, 雾化压力为0.2兆帕,喷雾速度为5ml/s。),粉碎过80目筛,得到清膏粉;按照清膏粉:糊精1:3的重量比称取清膏粉、糊精,将清膏粉与糊精投入槽型混合机中,搅拌20分钟,边搅拌边缓缓加入55%乙醇,至制成软材,用12目不锈钢筛制粒,65~75℃干燥2小时,取出,放凉即得所述的颗粒剂,按每袋15g包装。  Preparation process: Weigh the above-mentioned Chinese medicinal materials cleaned according to the prescription amount, combine them, add water to decoct twice, add water for the first time to 10 times the weight of the medicinal materials, decoct for 1.5 hours, and add water for the second time to 8 times the weight of the medicinal materials amount, decoct for 1.5h, combine the decoction, concentrate under reduced pressure at 0.07MPa, 60-70°C to an extract with a relative density of 1.15 at 65°C, add 95% (v/v) ethanol to make the alcohol content reach 75% (v/v), stir, stand still for 24 hours, filter, the filtrate is concentrated under reduced pressure at 0.07MPa and 65°C to a relative density of 1.25 at 65°C, and ethanol is recovered to obtain a concentrated solution, which is spray-dried (Conditions are that the inlet air temperature is 100°C, the outlet air temperature is 80°C, the material temperature is 80°C, the atomization pressure is 0.2 MPa, and the spray speed is 5ml/s.), crushed through a 80-mesh sieve to obtain clear cream powder ;Weigh the clear cream powder and dextrin according to the weight ratio of clear cream powder: dextrin 1:3, put the clear cream powder and dextrin into the tank mixer, stir for 20 minutes, and slowly add 55% ethanol while stirring , until soft material is made, granulate with 12 mesh stainless steel sieves, dry at 65~75°C for 2 hours, take out, let cool to get the described granules, pack in 15g per bag. the

实施例4  Example 4

生药处方:黄连18份、千层塔20份、薤白21份、五味子18份、竹叶22份、苏叶18份、薏苡仁26份、蒺藜15份、炙甘草10份、葶苈子15份。 Herbal medicine prescription: Coptidis 18 parts, Melaleuca 20 parts, Scallop 21 parts, Schisandra chinensis 18 parts, bamboo leaves 22 parts, perilla leaves 18 parts, coix seed 26 parts, tribulus terrestris 15 parts, roasted licorice 10 parts, Tinglizi 15 parts .

制备工艺:按处方量称取清洗干净的上述中药材,合并,加水煎煮两次,第一次加水为药材重量的10倍量,煎煮1.5h,第二次加水为药材重量的8倍量,煎煮1.5h,合并煎液,0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏,加95%(v/v)乙醇使含醇量达75%(v/v), 搅拌,静置24小时,过滤,滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25,并回收乙醇,得浓缩液,将浓缩液喷雾干燥(条件为进风温度为100℃,出风温度为80℃,物料温度为80℃, 雾化压力为0.2兆帕,喷雾速度为5ml/s。),粉碎过80目筛,得到清膏粉;按照清膏粉:糊精1:3的重量比称取清膏粉、糊精,将清膏粉与糊精投入槽型混合机中,搅拌20分钟,边搅拌边缓缓加入55%乙醇,至制成软材,用12目不锈钢筛制粒,65~75℃干燥2小时,取出,放凉即得所述的颗粒剂,按每袋15g包装。  Preparation process: Weigh the above-mentioned Chinese medicinal materials cleaned according to the prescription amount, combine them, add water to decoct twice, add water for the first time to 10 times the weight of the medicinal materials, decoct for 1.5 hours, and add water for the second time to 8 times the weight of the medicinal materials amount, decoct for 1.5h, combine the decoction, concentrate under reduced pressure at 0.07MPa, 60-70°C to an extract with a relative density of 1.15 at 65°C, add 95% (v/v) ethanol to make the alcohol content reach 75% (v/v), stir, stand still for 24 hours, filter, the filtrate is concentrated under reduced pressure at 0.07MPa and 65°C to a relative density of 1.25 at 65°C, and ethanol is recovered to obtain a concentrated solution, which is spray-dried (Conditions are that the inlet air temperature is 100°C, the outlet air temperature is 80°C, the material temperature is 80°C, the atomization pressure is 0.2 MPa, and the spray speed is 5ml/s.), crushed through a 80-mesh sieve to obtain clear cream powder ;Weigh the clear cream powder and dextrin according to the weight ratio of clear cream powder: dextrin 1:3, put the clear cream powder and dextrin into the tank mixer, stir for 20 minutes, and slowly add 55% ethanol while stirring , until soft material is made, granulate with 12 mesh stainless steel sieves, dry at 65~75°C for 2 hours, take out, let cool to get the described granules, pack in 15g per bag. the

实施例5 中药颗粒剂对病毒性心肌炎患者的疗效研究 Example 5 Study on the curative effect of Chinese medicine granules on patients with viral myocarditis

符合小儿病毒性心肌炎诊断标准的病毒性心肌炎患者42例,属气阴两虚、肝郁证辨证患者,其中男22例,女20例;年龄4岁以下8例,5~1O岁23例,11~14岁11例;平均病程17.1天。所有患者冲服中药颗粒剂(按照本发明实施例1的处方和工艺制备而成)3袋/d,早中晚各一袋,连续用药3周。观察并记录用药前后的临床症状体征。治疗结束后,按如下标准统计疗效: 42 patients with viral myocarditis who met the diagnostic criteria for viral myocarditis in children were patients with Qi and Yin deficiency and syndrome differentiation of liver depression, including 22 males and 20 females; 8 cases were under 4 years old, and 23 cases were 5-10 years old. 11 cases aged 11 to 14; the average course of disease was 17.1 days. All patients took 3 bags of traditional Chinese medicine granules (prepared according to the prescription and process of Example 1 of the present invention) every day, one bag each in the morning, noon and evening, for 3 consecutive weeks. Observe and record the clinical symptoms and signs before and after medication. After the treatment, the curative effect was counted according to the following standards:

显效:用药7~21天后主要症状消失或大部分消失,体征、心电图及心肌酶谱正常或接近正常; Significantly effective: after 7-21 days of medication, the main symptoms disappear or most of them disappear, and the signs, electrocardiogram and myocardial enzyme spectrum are normal or close to normal;

有效:用药7~21天后主要症状部分消失,体征、心电图及心肌酶谱有明显改善; Effective: after 7 to 21 days of medication, the main symptoms partially disappeared, and the signs, electrocardiogram and myocardial enzyme spectrum were significantly improved;

无效:用药7~21天后未达到疗效标准或出现严重心律失常或心源性休克。 Ineffective: After 7-21 days of medication, the curative effect standard is not reached or severe arrhythmia or cardiogenic shock occurs.

采用本发明的中药颗粒剂对42例病毒性心肌炎患者的治疗结果是:显效25例,有效14例,无效3例,总有效率92.86%。 The treatment results of 42 patients with viral myocarditis by adopting the traditional Chinese medicine granules of the present invention are: 25 cases are markedly effective, 14 cases are effective, 3 cases are ineffective, and the total effective rate is 92.86%.

患者治疗前后心肌酶谱改善情况比较见表l。 The improvement of myocardial enzyme spectrum before and after treatment is compared in Table 1.

表1 患者治疗前后心肌酶谱改善情况比较 Table 1 Comparison of improvement of myocardial enzyme spectrum in patients before and after treatment

Figure 2013107411132100002DEST_PATH_IMAGE001
Figure 2013107411132100002DEST_PATH_IMAGE001

与治疗前相比,* P<0.05。 * P <0.05 compared with before treatment.

另外,治疗结束后未发现患者对药物有过敏反应及不耐受现象,血、尿、便常规,心电图,肝肾功能未见异常。 In addition, after the treatment, no allergic reaction or intolerance to the drug was found in the patient, and no abnormalities were found in blood, urine, stool routine, electrocardiogram, liver and kidney function.

Claims (5)

1. a Chinese medicine composition for the treatment of viral myocarditis, is characterized in that: described Chinese medicine composition is prepared from by the traditional Chinese medicinal material raw materials of following weight portion: Rhizoma Coptidis 10-18 part, Herba Lycopodii serrati 20-30 part, Bulbus Allii Macrostemonis 20-30 part, Fructus Schisandrae Chinensis 10-18 part, Folium Bambusae 20-30 part, Folium Perillae 10-18 part, Semen Coicis 25-40 part, Fructus Tribuli 8-15 part, Radix Glycyrrhizae Preparata 6-12 part, Semen Lepidii (Semen Descurainiae) 10-18 part.
2. the Chinese medicine composition for the treatment of viral myocarditis according to claim 1, is characterized in that: described Chinese medicine composition is prepared from by the traditional Chinese medicinal material raw materials of following weight portion: Rhizoma Coptidis 13-15 part, Herba Lycopodii serrati 23-27 part, Bulbus Allii Macrostemonis 23-27 part, Fructus Schisandrae Chinensis 13-15 part, Folium Bambusae 23-27 part, Folium Perillae 13-15 part, Semen Coicis 30-35 part, Fructus Tribuli 10-13 part, Radix Glycyrrhizae Preparata 8-10 part, Semen Lepidii (Semen Descurainiae) 13-15 part.
3. treat according to claim 2 the Chinese medicine composition of viral myocarditis, it is characterized in that: described Chinese medicine composition is prepared from by the traditional Chinese medicinal material raw materials of following weight portion: 14 parts of Rhizoma Coptidis, 25 parts of Herba Lycopodii serratis, 25 parts of Bulbus Allii Macrostemonis, 14 parts of Fructus Schisandrae Chinensis, 25 parts, Folium Bambusae, 14 parts of Folium Perillae, 32 parts of Semen Coiciss, 12 parts of Fructus Tribulis, 8 parts of Radix Glycyrrhizae Preparatas, 14 parts of Semen Lepidii (Semen Descurainiae)s.
4. according to the Chinese medicine composition for the treatment of viral myocarditis described in claim 1 or 2 or 3, it is characterized in that: described Chinese medicine composition is oral formulations.
5. according to the Chinese medicine composition for the treatment of viral myocarditis described in claim 1 or 2 or 3, it is characterized in that: described Chinese medicine composition is granule.
CN201310741113.2A 2013-12-30 2013-12-30 A kind of traditional Chinese medicine composition for treating viral myocarditis Expired - Fee Related CN103690832B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310741113.2A CN103690832B (en) 2013-12-30 2013-12-30 A kind of traditional Chinese medicine composition for treating viral myocarditis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310741113.2A CN103690832B (en) 2013-12-30 2013-12-30 A kind of traditional Chinese medicine composition for treating viral myocarditis

Publications (2)

Publication Number Publication Date
CN103690832A true CN103690832A (en) 2014-04-02
CN103690832B CN103690832B (en) 2015-09-09

Family

ID=50352602

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310741113.2A Expired - Fee Related CN103690832B (en) 2013-12-30 2013-12-30 A kind of traditional Chinese medicine composition for treating viral myocarditis

Country Status (1)

Country Link
CN (1) CN103690832B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189598A (en) * 2014-09-18 2014-12-10 邓新连 Traditional Chinese medicine for treating qi stagnation and blood stasis type viral myocarditis
CN104474225A (en) * 2014-12-29 2015-04-01 牟利江 Medicine for treating viral myocarditis and preparation method
CN104906438A (en) * 2015-07-03 2015-09-16 车莉 Medicine for treating acute myocarditis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1785357A (en) * 2005-11-14 2006-06-14 咸阳步长医药科技发展有限公司 Chinese medicinal preparation for treating virus myocaraitis, its preparation method and quality control method
CN101757423A (en) * 2008-10-24 2010-06-30 常州善美药物研究开发中心有限公司 Traditional Chinese medicine composition for treating myocarditis and preparation method thereof
CN103520630A (en) * 2013-10-23 2014-01-22 孙丽 Traditional Chinese medicine for treating heart-qi deficiency syndrome type angina pectoris
CN103721030A (en) * 2012-10-15 2014-04-16 青岛信立德中药技术研究开发有限公司 Traditional Chinese medicine composition used for treating viral myocarditis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1785357A (en) * 2005-11-14 2006-06-14 咸阳步长医药科技发展有限公司 Chinese medicinal preparation for treating virus myocaraitis, its preparation method and quality control method
CN101757423A (en) * 2008-10-24 2010-06-30 常州善美药物研究开发中心有限公司 Traditional Chinese medicine composition for treating myocarditis and preparation method thereof
CN103721030A (en) * 2012-10-15 2014-04-16 青岛信立德中药技术研究开发有限公司 Traditional Chinese medicine composition used for treating viral myocarditis
CN103520630A (en) * 2013-10-23 2014-01-22 孙丽 Traditional Chinese medicine for treating heart-qi deficiency syndrome type angina pectoris

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
无: ""中药治疗病毒性心肌炎"", 《首都医药》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189598A (en) * 2014-09-18 2014-12-10 邓新连 Traditional Chinese medicine for treating qi stagnation and blood stasis type viral myocarditis
CN104474225A (en) * 2014-12-29 2015-04-01 牟利江 Medicine for treating viral myocarditis and preparation method
CN104474225B (en) * 2014-12-29 2015-07-08 牟利江 Medicine for treating viral myocarditis and preparation method
CN104906438A (en) * 2015-07-03 2015-09-16 车莉 Medicine for treating acute myocarditis

Also Published As

Publication number Publication date
CN103690832B (en) 2015-09-09

Similar Documents

Publication Publication Date Title
CN102813904B (en) Compound medicine for treating anaphylactic rhinitis-asthma syndrome and preparation method and application thereof
CN1471953A (en) A kind of medicinal plant composition for treating AIDS patients
CN103690832B (en) A kind of traditional Chinese medicine composition for treating viral myocarditis
CN101940621B (en) Chinese medicinal composition and preparation for relaxing bowel and preparation method thereof
CN103463425B (en) A traditional Chinese medicine extract for treating blood stasis and internal resistance, its preparation and preparation method
CN111973651A (en) Use of licorice root for treating diseases related to intestinal flora disturbance
CN105582124B (en) A kind of traditional Chinese medicine for treating constipation and preparation method thereof
CN105267559B (en) A kind of drug and preparation method thereof for treating diabete peripheral herve pathology
CN100569263C (en) A kind of pharmaceutical composition for treating stomachache and preparation method thereof
CN101167904B (en) A kind of pharmaceutical composition for treating hyperlipidemia and preparation method thereof
CN104524308A (en) Chinese herb decoction for treating sicca syndrome and making method thereof
CN103386113A (en) Traditional Chinese medicine composition, extractive and preparation for treating swine transmissible gastroenteritis and applications of Chinese medicine composition, extractive and preparation
CN103690825A (en) Weight reduction health care traditional Chinese medicine capsules
CN106110132A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN107952036B (en) Traditional Chinese medicine preparation for reducing blood sugar and preparation method thereof
CN105031339A (en) Traditional Chinese medicine composition for treating stomatitis
CN104758676A (en) Medicine for treating damp-heat in resistance-type epigastric pain
CN105797092B (en) Yiyuan anti-cold mixture
CN104667020B (en) A kind of pharmaceutical composition for treating anaphylactoid purpura and preparation method thereof
CN109125576A (en) A kind of traditional Chinese medicine preparation for adjuvant treatment of gastritis and production method
CN111743952A (en) The use of habitat in regulating gut microbes
CN108186909A (en) The Chinese medicine composition and its compound preparation of improvement insulin resistance syndrome and application
CN101879302A (en) A compound traditional Chinese medicine for treating chronic arrhythmia and its preparation method
CN118831142A (en) Traditional Chinese medicine composition for improving antibody titer of novel coronavirus vaccine
CN121466259A (en) Eighteen-ingredient turbidity-eliminating composition and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20170503

Address after: 226200 Hopewell Town, Qidong, Jiangsu, Nantong

Patentee after: QIDONG JIULONG SHUNZHOU TOY FACTORY

Address before: 266200 Jimo, Qingdao, the Yellow River, No. two, No. Road, building 25, building 182

Patentee before: Wang Xueyan

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150909